The Extracorporeal Shock Wave Lithotripsy Market is growing significantly due to increasing prevalence of kidney stones among population worldwide. According to the National Institute of Diabetes and Digestive and Kidney Diseases, about 10% of the population will experience kidney stones at some point in their lifetime. Kidney stones typically require treatment, creating demand for lithotripsy procedures and associated medical devices and equipment.

The Extracorporeal Shock Wave Lithotripsy Market is estimated to be valued at US$ 443 Mn in 2023 and is expected to exhibit a CAGR of 6.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive medical procedure used to treat kidney stones and gallbladder stones. During an ESWL procedure, shock waves are targeted at a kidney stone from outside the body to break it up into smaller fragments that can pass through the urinary system naturally. It is considered a minimally-invasive procedure that does not require incision or anesthesia. ESWL helps in breaking down stones into tiny grains that can easily pass out in urine, reducing patient discomfort.

Market key trends:

Technological advancements are expected to drive the Global Extracorporeal Shock Wave Lithotripsy Market Size growth over the forecast period. Key players are focusing on developing advanced lithotripter devices with improved efficiency. For instance, in 2019, Dornier MedTech introduced Dornier Delta III lithotripter device equipped with new technologies including Comfort Wave technology and E-SWL Mode. This device provides high stone fragmentation rates with minimal side effects. Similarly, EDAP TMS launched Focal One HIFU device in 2018 combining high intensity lithotripsy and high intensity focused ultrasound technologies for kidney stone treatment. Such innovative devices offer enhanced treatment options to urologists and patients.

Porter’s Analysis

Threat of new entrants: Low capital requirements and existing technologies lower the barriers for new companies to enter the market. However, strong brand loyalty and need for extensive service and support networks limits entry.

Bargaining power of buyers: Individual consumers have low bargaining power but larger healthcare organizations and groups can negotiate on price and contracts. This influences pricing in the market.

Bargaining power of suppliers: A few large companies dominate the supply of core device components giving them significant bargaining power over OEMs. However, overall supplier power remains balanced due to availability of substitutes.

Threat of new substitutes: New less invasive lithotripsy procedures pose a threat but most are still in development or limited to specific cases. Overall threat remains moderate.

Competitive rivalry: Intense competition between major players to gain market share through innovative devices and comprehensive service offerings.

SWOT Analysis

Strengths: Well-established technology with proven clinical efficacy. Major players have strong brand equity and global presence.

Weaknesses: High dependency on reimbursement policies impacts device replacements and upgrades. Procedures require specialized skills and tend to be expensive.

Opportunities: Rising geriatric population increases prevalence of urolithiasis. Adoption in pediatric cases can further drive growth.

Threats: Cost-containment measures and lack of uniform reimbursement coding limits procurement. Increased adoption of alternatives like minimally invasive surgeries.

For More Insights, Read- https://www.feedsfloor.com/pharmaceuticals/extracorporeal-shock-wave-lithotripsy-market-estimated-be-valued-us-443-mn-2023